Nothing Special   »   [go: up one dir, main page]

CN104435166A - Traditional Chinese medicine composition containing panax japonicus for reducing blood pressure - Google Patents

Traditional Chinese medicine composition containing panax japonicus for reducing blood pressure Download PDF

Info

Publication number
CN104435166A
CN104435166A CN201410633417.1A CN201410633417A CN104435166A CN 104435166 A CN104435166 A CN 104435166A CN 201410633417 A CN201410633417 A CN 201410633417A CN 104435166 A CN104435166 A CN 104435166A
Authority
CN
China
Prior art keywords
parts
blood pressure
chinese medicine
medicine composition
pressure lowering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410633417.1A
Other languages
Chinese (zh)
Inventor
骆均勇
成建国
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENGDU HUAXI TECHNOLOGY Co Ltd
Original Assignee
CHENGDU HUAXI TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENGDU HUAXI TECHNOLOGY Co Ltd filed Critical CHENGDU HUAXI TECHNOLOGY Co Ltd
Priority to CN201410633417.1A priority Critical patent/CN104435166A/en
Publication of CN104435166A publication Critical patent/CN104435166A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/59Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition containing panax japonicus for reducing blood pressure, belonging to the technical field of medicines. The traditional Chinese medicine composition containing panax japonicus for reducing blood pressure is prepared from the following medicinal raw materials in parts by weight: 5-20 parts of peony leaves, 4-15 parts of ginkgo leaves, 3-10 parts of panax japonicus, 3-10 parts of algae, 3-10 parts of caulis sinomenii, 1-5 parts of common macrocarpium fruit and 1-5 parts of swine blood meal. According to the traditional Chinese medicine composition for reducing blood pressure, disclosed by the invention, the seven medicinal raw materials have synergistic interaction functions after being combined in proportion, significant curative effects on treatment of high blood pressure can be achieved, and significant side effects and adverse reactions cannot be caused.

Description

A kind of blood pressure lowering Chinese medicine composition containing Rhizoma Panacis Japonici
Technical field
The present invention relates to a kind of Chinese medicine composition, be specifically related to a kind of blood pressure lowering Chinese medicine composition containing Rhizoma Panacis Japonici, belong to medical art.
Background technology
Hypertension increases clinical syndrome for main manifestations with systemic arterial pressure, is modal cardiovascular disease.Hypertension can be divided into constitutional and the large class of Secondary cases two.In most patient, hypertensive etiology unknown, is referred to as essential hypertension, accounts for total hyperpietic's more than 95%; Less than in 5% patient, it is a kind of clinical manifestation of some disease that blood pressure raises, and itself has clearly and the independently cause of disease, is called secondary hypertension.Essential hypertension, also known as hypertension, usual onset is slow, often asymptomatic in early days, for many years conscious well even discovery blood pressure rising when physical examination, and small number of patients then just can be found after the complication such as the generation heart, brain, kidney.
Hypertension incidence is high, can bring out the generation of the disease such as coronary heart disease, cerebral hemorrhage, and great majority cause a series of damage of the vitals such as the heart, brain, kidney and serious pathological changes, or even nonfunction, and sugared, eagle matter metabolism disorder, very large threat is caused to the healthy of people.According to statistics, whole world Prevalence of Hypertension, up to 10%-20%, is suffered from hypertensive number and is reached 1,000,000,000, dies from per year over l200 ten thousand people the various diseases that hypertension causes.Population of China Prevalence of Hypertension is in rising trend, three national hypertension investigation displays.The sickness rate of l959 is 5.11%.L979-1980 annual morbidity is 7.73%, l990-1991 annual morbidity is 11.26%, and the existing hyperpietic of China has exceeded l.2 hundred million people, and annual still with the speed increase of more than 600 ten thousand people.According to World Health Organization's prediction, to the year two thousand twenty, noninfectious will account for 79% of China's cause of death.Wherein the cardiovascular disease such as hypertension will account for first place.Therefore, prevention and therapy hypertension has become the focus of society research; It is one of significant problem urgently to be resolved hurrily at present.
Hypertension is a kind of chronic disease needing long-term monitoring and treatment, needs to take medicine throughout one's life.Existing Altace Ramipril is generally Western medicine, and Long-term taking medicine can have larger side effect to the liver of human body, kidney etc., and easily causes the uncomfortable reaction such as cough, edema, dizziness.Therefore, be necessary to find a kind of little to health side effect, low-cost effective hypotensor.
Summary of the invention
To the object of the invention is to overcome in prior art existing above-mentioned deficiency, a kind of blood pressure lowering Chinese medicine composition is provided, this Chinese medicine composition low price, little to patient body side effect for blood pressure lowering good effect.
In order to realize foregoing invention object, the invention provides following technical scheme:
Containing a blood pressure lowering Chinese medicine composition for Rhizoma Panacis Japonici, it is prepared from by the medicinal raw material of following weight proportion: leaf of paeonia suffruticosa ardr. 5 ~ 20 parts, Folium Ginkgo 4 ~ 15 parts, Rhizoma Panacis Japonici 3 ~ 10 parts, Sargassum 3 ~ 10 parts, Caulis Sinomenii 3 ~ 10 parts, Fructus Corni 1 ~ 5 part, Swine blood meal 1 ~ 5 part.Described various medicinal raw material is the Chinese crude drug meeting country or provincial standard and specify.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by leaf of paeonia suffruticosa ardr. is 9 ~ 15 parts.Preferred, part by weight shared by leaf of paeonia suffruticosa ardr. is 12 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Folium Ginkgo is 7 ~ 12 parts.Preferred, part by weight shared by Folium Ginkgo is 9 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Rhizoma Panacis Japonici is 5 ~ 8 parts.Preferred, part by weight shared by Rhizoma Panacis Japonici is 6 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Sargassum is 5 ~ 8 parts.Preferred, part by weight shared by Sargassum is 6 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Caulis Sinomenii is 5 ~ 8 parts.Preferred, part by weight shared by Caulis Sinomenii is 6 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Fructus Corni is 2 ~ 4 parts.Preferred, part by weight shared by Fructus Corni is 3 parts.
Preferably, in above-mentioned medicinal raw material proportioning, part by weight shared by Swine blood meal is 2 ~ 4 parts.Preferred, part by weight shared by Swine blood meal is 3 parts.
The present invention is used for the Chinese medicine composition of blood pressure lowering, the active component of medicinal raw material can be extracted according to extracting method conventional on Chinese materia medica, add pharmaceutically acceptable carrier or/and adjuvant, as starch, dextrin, microcrystalline cellulose, amylum pregelatinisatum, magnesium stearate, micropowder silica gel, sucrose, carboxymethyl starch sodium, hydroxypropyl emthylcellulose, vegetable oil, lecithin, Polyethylene Glycol, propylene glycol, ethyl hydroxybenzoate etc., make dosage form suitable on pharmaceutics, as granule, tablet, hard capsule, oral liquid, soft capsule, drop pill, water pill etc.
The extracting method of Chinese medicine composition of the present invention can adopt but be not limited to following methods:
(1) get each medicinal raw material by formula proportion, in medicinal raw material, add 60 ~ 80% ethanol or the water of medicinal raw material volume 8 ~ 10 times; Reflux, extract, 2 ~ 3 times; Extraction time is respectively 1 ~ 2h; Collect merge extractive liquid, and extracting solution is condensed into extractum, dry, obtain the extract of medicinal raw material of the present invention.
(2) in above-mentioned extract, add pharmaceutic adjuvant and be mixed and made into acceptable various pharmaceutical dosage form on pharmaceutics.
According to the needs of the various drug form of preparation, medicine of the present invention also can add suitable pharmaceutic adjuvant as filler, disintegrating agent, binding agent, lubricant, antiseptic etc. in preparation process.
Compared with prior art, beneficial effect of the present invention:
The present invention be used for blood pressure lowering Chinese medicine composition, be inventor based on motherland's medical science to hypertensive pathogenetic understanding, according to oneself clinical experience for many years, first determine a series of to the effective Chinese medicine of blood pressure lowering from numerous Chinese medicine, repeatedly verify through clinical again, screen.Wherein, leaf of paeonia suffruticosa ardr., bitter in the mouth, light, property is put down, and returns liver, spleen channel; There is blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood, anti-inflammatory, antibacterial, tranquillizing and allaying excitement, blood pressure lowering, enhancing immunity, promotion skin microcirculation, slow down the effects such as pigementation.Folium Ginkgo, another name moth leaf, duck bottom sediment; For the dried leaves of Ginkgoaceae plant Ginkgo biloba (maidenhair tree, Gong Sunshu); Sweet, bitter, puckery, flat; GUIXIN, lung meridian; Have and astringe the lung, relieving asthma, blood circulation promoting and blood stasis dispelling, effect of pain relieving; For cough and asthma due to lung deficiency; Coronary heart disease, angina pectoris, the diseases such as hyperlipidemia.Rhizoma Panacis Japonici, another name Herba Rhodiolae Henryi, bright seven, Rhizoma Tupistrae Chinensis, Radix Raphani seven, Rhizoma cypripedii macranthi, Radix Panacis japonici, wild Radix Notoginseng, panax japonicus, branches and leaves of Munronia hainanensis Howet T.Chen; For the dry rhizome of Araliaceae Rhizoma Panacis Japonici; Sweet, micro-hardship, temperature; Return liver, spleen, lung meridian; There is strengthening by means of tonics, eliminating stasis to stop pain, effect of eliminating the phlegm of stopping blooding; For weak after being ill, chronic cough is spat blood, cough with copious phlegm, the diseases such as injury from falling down.Sargassum is the dry frond of Sargassaceae plant Sargassum or Sargassum fusiforme (Harv.) Setch; Bitter, salty, cold; Return liver, stomach, kidney channel; There is hard masses softening and resolving, expectorant, effect of diuretic; For goiter, scrofula, painful and swollen testis, the diseases such as phlegm retention edema.Caulis Sinomenii, another name Herba Anemones vitifoliae, Caulis Seu Radix Kadsurae Oblongifoliae, black Radix Stephaniae Tetrandrae, Solanum lyratum Thunb., blue or green Radix Stephaniae Tetrandrae; For the dry rattan of menispermaceous plants Sinomenium acutum and hair Sinomenium acutum; Bitter, pungent, flat; Return liver, spleen channel; There is wind-damp dispelling, the meridian dredging, effect of diuresis; For rheumatic arthralgia, arthroncus, the diseases such as paralysis pruritus.Fructus Corni is the drying and ripening sarcocarp of Cornaceae plant Fructus Corni; Sour, puckery, tepor; Return liver, kidney channel; There is liver and kidney tonifying, effect of essence astringing and desertion stemming; For vertigo and tinnitus, soreness of waist and knee joint, impotence and seminal emission, enuresis frequent micturition, bleeding not during menses, the diseases such as profuse sweating is collapsed, interior-heat is quenched one's thirst.Swine blood meal is the dried powder of the blood of porcine animals pig; Salty in the mouth; Property is put down; GUIXIN, Liver Channel; There is replenishing blood for nourishing heart, relieving convulsion, the therapeutic method to keep the adverse QI flowing downwards of relieving dizziness, high fever, infantile convulsions, epilepsy, etc., hemostasis effect; Main phlegm-accumulating vertigo, epilepsy infantile convulsion, fullness in the epigastrium and abdomen abdominal distention, sensation of gas rushing are inverse, blood, cervical erosion are leaked down in pouring.Above-mentioned 7 taste Chinese herbal medicine, flavour of a drug are few but function is complete, 7 taste medicinal raw materials are by after described proportioning combination, for blood pressure lowering, there is Synergistic function, experimental study shows, Chinese medicine composition of the present invention is used for blood pressure lowering instant effect, good effect, and administration is after one week, can to take effect and evident in efficacy, and not occur obvious adverse reaction during patient consumes.
Detailed description of the invention
Below in conjunction with test example and detailed description of the invention, the present invention is described in further detail.But this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following embodiment, all technology realized based on content of the present invention all belong to scope of the present invention.
In embodiments of the invention and comparative example, ethanol used is the aqueous solution of ethanol, and the percentage composition of ethanol, if no special instructions, is volumn concentration.
Embodiment 1
The present embodiment is used for the Chinese medicine composition of blood pressure lowering, is be prepared from by the medicinal raw material of following weight proportion: leaf of paeonia suffruticosa ardr. 12g, Folium Ginkgo 9g, Rhizoma Panacis Japonici 6g, Sargassum 6g, Caulis Sinomenii 6g, Fructus Corni 3g, Swine blood meal 3g.
The extracting method of above-mentioned medicinal raw material:
(1) get each medicinal raw material by formula proportion, in medicinal raw material, add 60 ~ 80% ethanol or the water of medicinal raw material volume 8 ~ 10 times; Reflux, extract, 2 ~ 3 times; Extraction time is respectively 1 ~ 2h; Collect merge extractive liquid, and extracting solution is condensed into extractum, dry, obtain the extract of the medicinal raw material of embodiment 1.
(2) in above-mentioned extract, add the soluble starch of extract weight 2 times of weight, granulate, dry, be distributed into bag, obtain granule.
Embodiment 2
The present embodiment is used for the Chinese medicine composition of blood pressure lowering, is be prepared from by the medicinal raw material of following weight proportion: leaf of paeonia suffruticosa ardr. 20g, Folium Ginkgo 4g, Rhizoma Panacis Japonici 10g, Sargassum 3g, Caulis Sinomenii 10g, Fructus Corni 1g, Swine blood meal 5g.
The above-mentioned medicinal raw material of the present embodiment for the preparation of the method for the Chinese medicine composition of blood pressure lowering with embodiment 1.
Embodiment 3
The present embodiment is used for the Chinese medicine composition of blood pressure lowering, is be prepared from by the medicinal raw material of following weight proportion: leaf of paeonia suffruticosa ardr. 13g, Folium Ginkgo 8g, Rhizoma Panacis Japonici 7g, Sargassum 7g, Caulis Sinomenii 5g, Fructus Corni 4g, Swine blood meal 2g.
The above-mentioned medicinal raw material of the present embodiment for the preparation of the method for the Chinese medicine composition of blood pressure lowering with embodiment 1.
Comparative example
This comparative example is used for the Chinese medicine composition of blood pressure lowering, is be prepared from by the medicinal raw material of following weight proportion: leaf of paeonia suffruticosa ardr. 12g, Folium Ginkgo 9g, Sargassum 6g, Caulis Sinomenii 6g, Fructus Corni 3g, Swine blood meal 3g.
The above-mentioned medicinal raw material of this comparative example for the preparation of the method for the Chinese medicine composition of blood pressure lowering with embodiment 1.
Pharmacodynamics and toxicity test:
In order to the efficacy and saferry of proved invention medicine, inventors performed pharmacodynamics and toxicity test investigation.The research method adopted and result of the test as follows:
1, test objective: the present invention is used for the Chinese medicine composition of blood pressure lowering to the hypotensive activity of original hypertensive rat.
2, test material
(1) medicine and reagent:
According to the Chinese medicine composition (making oral liquid) of embodiment 1 prepared by embodiment 1;
According to the Chinese medicine composition of comparative example prepared by comparative example, (making oral liquid);
Nifedipine Tablets: HARBIN PHARMACEUTICAL GROUP CO., LTD. General Pharm. Factory, (making oral liquid).
(2) animal: choose the original hypertensive rat 40 purchased from the laboratory animal department of the Chinese Academy of Sciences of Huaxi Medical Univ, body weight is 200 ~ 250g; Raise in positive pressure purification ventilation Animal House, room temperature 25 ± 2 DEG C, ad lib and drinking-water.
3, test method and result
Pretreatment before test: tested rat is put into measuring cell and carries out training 2 weeks, and blood pressure is measured second week rises the next day.The electrocaloric effect that before pressure measurement, animal puts into 37 ± 1 DEG C is heated, and measures rat systolic pressure after 15 minutes with RBP-1 type rat blood pressure instrument (Institute of Basic Medical Sciences of China-Japan Friendship Hospital, Beijing).
Process of the test: original hypertensive rat is divided into 4 groups at random, drug study group of the present invention, matched group 1, positive controls and model control group, often organize 10.The Chinese medicine composition oral liquid (7g raw medicinal herbs/kg, 1.5mL/50g) that the oral embodiment of the present invention of drug study group of the present invention 1 is obtained; The Chinese medicine composition oral liquid (7g raw medicinal herbs/kg, 1.5mL/50g) that the oral comparative example of the present invention of matched group 1 is obtained; Positive controls oral nifedipine sheet oral liquid (10mg/kg); The oral same volume distilled water of model control group, once a day, continuous 5 weeks.During administration and the ingesting of the mice respectively organized of fore-and-aft observing, movable and excretion situation situation all without exception occur.After administration the 1st, 2,3,4,5 weekends, measure the systolic pressure of rat, to measure 3 times at every turn, average.The blood pressure determination time after administration carries out after 2 hours in administration, and has measured in 4 hours upon administration.
Result of the test:
Adopt SPSS software to carry out statistical analysis, result of the test all represents with x ± s, and many group means compare employing ANOVA variance analysis, compare and check with q between group; There is significant P≤0.05 for difference.Result of the test is as shown in table 1, and table 1 was depicted as administration after 1 week, continuous 5 measurement statistical results to original hypertensive rat systolic pressure (unit: mmHg).
Table 1
Note: compare with model group: *p<0.05; Compare with matched group 1: ▲ ▲p<0.05.
Experimental data in table 1 shows: the original hypertensive rat taking Chinese medicine composition oral liquid prepared by the embodiment of the present invention 1, administration is after 1 week, blood pressure starts to decline, continuously to the 4th weekend only, blood pressure is down to and is similar to normal value and substantially equal with the pressure value of positive controls; About 44mmHg is reduced relative to the rat blood pressure shrinkage value of model control group, and the Exemplary statistical data relative model matched group P<0.05 of medicine group of the present invention, there is significant difference.The present invention is used for the Chinese medicine composition of blood pressure lowering, for blood pressure lowering instant effect, good effect.
And matched group 1 shown in table 1 records rat blood pressure shrinkage value, after administration, blood pressure drops speed is slower.And administration is after 3 weeks, rat blood pressure shrinkage value still at about 120mmHg, and has no further decline.Chinese medicine composition for blood pressure lowering prepared by comparative example of the present invention, blood pressure lowering effect is poor; And the rat blood pressure shrinkage value statistical data of drug study group of the present invention is relative to the rat blood pressure shrinkage value statistical data P < 0.05 of matched group 1, has significant difference.Learn thus, the present invention is used for 7 kinds of medicinal raw materials of blood pressure lowering by after described weight proportion combination, and have Synergistic function, can significantly improve the curative effect of Chinese medicine composition, lack any component, the curative effect of Chinese medicine composition all significantly declines.
In sum, the present invention is containing the Chinese medicine composition for blood pressure lowering of Rhizoma Panacis Japonici, and for hyperpietic's blood pressure lowering short treating period, instant effect, administration can take effect and evident in efficacy for 1 week.7 kinds of medicinal raw materials, by after described weight proportion combination, have Synergistic function, can significantly improve the hypertensive curative effect of traditional Chinese medicine composition for treating; Lack any component, its curative effect all significantly declines, therapeutic effect as matched group 1 significantly reduces relative to the therapeutic effect of drug study group of the present invention, and blood pressure lowering traditional Chinese medicine composition for treating hypertension of the present invention is little to patient body side effect, is applicable to hyperpietic's long-term taking.

Claims (10)

1., containing a blood pressure lowering Chinese medicine composition for Rhizoma Panacis Japonici, it is characterized in that: it is prepared from by the medicinal raw material of following weight proportion: leaf of paeonia suffruticosa ardr. 5 ~ 20 parts, Folium Ginkgo 4 ~ 15 parts, Rhizoma Panacis Japonici 3 ~ 10 parts, Sargassum 3 ~ 10 parts, Caulis Sinomenii 3 ~ 10 parts, Fructus Corni 1 ~ 5 part, Swine blood meal 1 ~ 5 part.
2. blood pressure lowering Chinese medicine composition according to claim 1, is characterized in that: part by weight shared by leaf of paeonia suffruticosa ardr. is 9 ~ 15 parts.
3. blood pressure lowering Chinese medicine composition according to claim 2, is characterized in that: part by weight shared by leaf of paeonia suffruticosa ardr. is 12 parts.
4. blood pressure lowering Chinese medicine composition according to claim 1, is characterized in that: part by weight shared by Folium Ginkgo is 7 ~ 12 parts.
5. blood pressure lowering Chinese medicine composition according to claim 1, is characterized in that: part by weight shared by Rhizoma Panacis Japonici is 5 ~ 8 parts.
6. blood pressure lowering Chinese medicine composition according to claim 1, is characterized in that: part by weight shared by Sargassum is 5 ~ 8 parts.
7. blood pressure lowering Chinese medicine composition according to claim 1, is characterized in that: part by weight shared by Caulis Sinomenii is 5 ~ 8 parts.
8. blood pressure lowering Chinese medicine composition according to claim 1, is characterized in that: part by weight shared by Fructus Corni is 2 ~ 4 parts.
9. blood pressure lowering Chinese medicine composition according to claim 1, is characterized in that: part by weight shared by Swine blood meal is 2 ~ 4 parts.
10. blood pressure lowering Chinese medicine composition according to claim 9, is characterized in that: part by weight shared by Swine blood meal is 3 parts.
CN201410633417.1A 2014-11-11 2014-11-11 Traditional Chinese medicine composition containing panax japonicus for reducing blood pressure Pending CN104435166A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410633417.1A CN104435166A (en) 2014-11-11 2014-11-11 Traditional Chinese medicine composition containing panax japonicus for reducing blood pressure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410633417.1A CN104435166A (en) 2014-11-11 2014-11-11 Traditional Chinese medicine composition containing panax japonicus for reducing blood pressure

Publications (1)

Publication Number Publication Date
CN104435166A true CN104435166A (en) 2015-03-25

Family

ID=52882428

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410633417.1A Pending CN104435166A (en) 2014-11-11 2014-11-11 Traditional Chinese medicine composition containing panax japonicus for reducing blood pressure

Country Status (1)

Country Link
CN (1) CN104435166A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101558879A (en) * 2009-02-23 2009-10-21 铜陵凯润牡丹生物医药科技有限公司 Teabag containing peony leaves for tranquilizing mind and its preparation method
CN103222621A (en) * 2013-05-09 2013-07-31 北京华元堂生物科技有限公司 Body benefiting and oxidation resisting healthcare product

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101558879A (en) * 2009-02-23 2009-10-21 铜陵凯润牡丹生物医药科技有限公司 Teabag containing peony leaves for tranquilizing mind and its preparation method
CN103222621A (en) * 2013-05-09 2013-07-31 北京华元堂生物科技有限公司 Body benefiting and oxidation resisting healthcare product

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
宫乐辉等,: "《现代医学诊疗前沿》", 31 March 2009, 内蒙古科学技术出版社 *
曾育麟等,: "《中国民族药志》", 31 December 2007, 四川民族出版社 *
谢丽娟: "《家庭养生常识1000例》", 31 March 2013, 贵州科技出版社 *

Similar Documents

Publication Publication Date Title
CN102813801B (en) Traditional Tibetan medicine for treating cough and preparation method thereof
CN101002906A (en) Compounding traditional Chinese medicine, and its use
CN103520572A (en) Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition
CN102205107A (en) Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof
CN106177053A (en) A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Pericarpium Citri Reticulatae
CN103301356A (en) Preparation method of enema for chronic renal failure
CN106177432A (en) A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja, Folium Mori, green tea and Rhizoma Polygonati Odorati
CN103301355A (en) Preparation method of chronic renal failure colon dialysate
CN101732585A (en) Medicinal composition for treating migraine, preparation method and application thereof
CN104435567A (en) Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout
CN103735871A (en) Chinese medicinal composition for treating neurasthenia and preparation method thereof
CN103446445A (en) Traditional Chinese medicine preparation for treating qi-yin deficiency-type chronic bronchitis and preparation method thereof
CN105833055A (en) Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia and preparing method and application thereof
CN105194355A (en) Traditional Chinese medicine preparation for treating primary hypertension
CN105106634A (en) Traditional Chinese medicine preparation for treating acute appendicitis and application thereof
CN104435166A (en) Traditional Chinese medicine composition containing panax japonicus for reducing blood pressure
CN105663439A (en) Pharmaceutical composition for preventing and treating diabetes and preparation method thereof
CN104352561A (en) Radix achyranthis bidentatae-containing traditional Chinese medicine composition for lowering blood pressure
CN104435079A (en) Traditional Chinese medicinal composition for treating gout
CN104352672A (en) Tortoise plastron-containing traditional Chinese medicine composition for treating diabetes
CN104435814A (en) Traditional Chinese medicine composition containing cyclocarya paliurus and having function of reducing blood pressure
CN103845447B (en) A kind of pure Traditional Chinese medicine health-preserving preparation with replenishing QI to invigorate the spleen nourishing the liver, the tranquilizing by nourishing the heart function that nourishes blood
CN105943860A (en) Medicine preparation for treating diabetes mellitus and preparation method thereof
CN104383012A (en) Traditional Chinese medicine composition containing phoenix tree leaf for reducing blood pressure
CN104645061A (en) Medicine for treating blood stasis stationary chronic gastric ulcer and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150325